499 VERY-EARLY VIRAL RESPONSE (WEEK-1) TO TRIPLE THERAPY WITH TELAPREVIR, PEG-INTERFERON AND RIBAVIRIN PREDICTS EXTENDED-RVR AND TREATMENT OUTCOMES IN PATIENTS WITH HCV GENOTYPE 1.
- Resource Type
- Abstract
- Source
Journal of Hepatology . Apr2013 Supplement 1, Vol. 58, pS204-S205. 0p.- Subject
- Language
- ISSN
- 0168-8278